BSE Healthcare index hits new high
Ranbaxy, Divi's Lab, Sun Pharma, Strides Arcolab,
Lupin, Biocon, Dr Reddy's and Wockhardt are up 2-5% on BSE.
Nifty opens above 7,500; Pharma shares in demand
Main gainers on the Sensex are Sun Phrama, Dr Reddy's Labs, NTPC, ONGC and Coal India
Ranbaxy hits 52-week high on US FDA nod for Diovan generic
The stock has surged 6% to Rs 503 on the National Stock Exchange.
Pre-Market: 5 stocks in spotlight
Here are a few stocks that you need to keep a tab on today
High rollovers as market bets big on the Budget
The Nifty futures rollover stood at 71.4%, compared to the previous three-month average of 58%
Ranbaxy Laboratories received the US Food and Drug Administration approval to sell a generic version of Novartis’s hypertension medicine Diovan
ReplyDeleteStock Cash
I really enjoy reading this, and also agreed with your conclusions. It was a awe-inspiring post, I have some news:- Reliance Capital ended up 1.7% on a report that Japan's Sumitomo Mitsui Trust Holdings Inc may buy 10% stake in the Anil Ambani-owned company by paying $400 million for new shares.
ReplyDeleteSectoral oil & gas stocks will remain on investors' radar after media reports suggest that Indian oil ministry seeks cut in excise duty on petrol, diesel in the upcoming 2018-19 budget to cushion the impact of rising oil prices.
ReplyDeleteShare Market Company